跳至主要内容
临床试验/NCT04763317
NCT04763317招募中不适用

Precision Medicine in the Prostate Cancer Care Pathway: an Evaluation of Integrating Germline Genetic Testing Into the Management of Men at Risk of / Living With Prostate Cancer

Institute of Cancer Research, United Kingdom1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2019年2月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
3,000
试验地点
1
主要终点
Prevalence of genetic variation in affected men

研究概览

简要总结

This study aims to evaluate the use of a prostate cancer specific predisposition genetic panel test in men with / at high risk of prostate cancer. The genetic test will analyse men's DNA samples for the presence of mutations in rare genes as well as common genetic variation to provide men with information about their risk of prostate cancer. This study will evaluate the clinical impact of the test on risk assessment and clinical management in terms of screening and treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Affected cohort:
  • Affected with PrCa < 60 years or
  • Affected with metastatic castration resistant PrCa (mCRPC) at any age or Aggressive PrCa Gleason 4+4 or higher <70 years
  • Affected with family history defined as three or more cases any age (FDR or SDR)
  • Unaffected cohort: (This cohort is no longer recruiting, it has completed recruitment)
  • Aged >30 and with a family history defined as:
  • FDR diagnosed < 70
  • 2 or more cases in First or Second Degree Relatives (FDR/SDR) with one case diagnosed < 70 years
  • 3 or more cases at any age (on same side of family)

排除标准

  • • WHO performance status 4

结局指标

主要结局

Prevalence of genetic variation in affected men

时间窗: Through study completion, an average of 1 year

To determine the prevalence of prostate cancer (PrCa) specific genetic variation in men with: (a)young onset PrCa; (b) metastatic PrCa; (c) men with PrCa and a family history of PrCa compared with controls.

次要结局

  • Prostate Cancer genetic variation on clinical outcome(Through study completion, an average of 1 year)
  • Prevalence of genetic variation in unaffected men(Through study completion, an average of 1 year)

研究者

发起方
Institute of Cancer Research, United Kingdom
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Precision Medicine in the Prostate Cancer Care... | 临床试验